Research sheds light on crimean-congo hemorrhagic fever disease process
Study shows that VEGF-A can increase expression of dopamine D2 receptors on endothelial cells
20 May 2022Regulatory, patent reform needed for inhalers for asthma, COPD
21 May 2022Research sheds light on crimean-congo hemorrhagic fever disease process
Army scientists determined that the body’s own natural immune response contributes to disease severity in mice infected with Crimean-Congo hemorrhagic fever virus (CCHFV), which causes a widespread tick-borne viral infection in humans. Their work, published May 19, 2022 in PLoS Pathogens, provides a deeper understanding of how the virus causes disease and forms a basis for developing medical countermeasures to prevent and treat infection.
